… and new ways to detect and diagnose lung cancer earlier. This review will summarize the
advances and current controversies in the management of lung cancers, many of which have …

… Lung cancer is diagnosed at an advanced stage in a majority of patients, which is the
primary reason behind the high mortality rate associated with this disease. Early detection …

… Small cell lung cancer (SCLC) is an aggressive neuroendocrine tumor with clinical and …
The frequency of SCLC as a proportion of all lung cancer cases peaked at 17% to 20% in …

… the diagnosis and management of patients with lung cancer does not have to be difficult and
… , addressing tobacco use in conjunction with advances in lung cancer therapy will provide …

… Radon, a naturally occurring carcinogen, is among the risk factors linked with lung cancer,
and approximately 21,000 lung cancer deaths in the United States have been linked to radon …

… 88% of preventable lung cancer deaths and reduced the … of lung cancer heralds a new
era in lung cancer research and will hopefully shift the disease from diagnosis at an advanced …

… from targeting advanced clinically manifest lung cancer toward asymptomatic preinvasive
and early-invasive cancer is occurring. The present article reviews the recent advances in the …

… to improve survival for patients with lung cancer. Targeted therapeutic agents, based on …
altered in lung cancer, have added significantly to our armamentarium for lung cancer treatment …

… Lung cancer is the leading cause of cancer-related deaths in the United States, the majority
of which are from non-small cell lung cancer (… approach to treat locally advanced NSCLC (LA-…

… cancer, only a small proportion of patients are … lung cancer (SCLC) and non–small cell lung
cancer (NSCLC). In addition, the potential role of screening for lung cancer and advances in …